DE69938579D1 - Extrazelluläre Matrixproteine mit modifizierten Aminosäuren - Google Patents
Extrazelluläre Matrixproteine mit modifizierten AminosäurenInfo
- Publication number
- DE69938579D1 DE69938579D1 DE69938579T DE69938579T DE69938579D1 DE 69938579 D1 DE69938579 D1 DE 69938579D1 DE 69938579 T DE69938579 T DE 69938579T DE 69938579 T DE69938579 T DE 69938579T DE 69938579 D1 DE69938579 D1 DE 69938579D1
- Authority
- DE
- Germany
- Prior art keywords
- amino acids
- extracellular matrix
- modified amino
- matrix proteins
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 title 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4725—Proteoglycans, e.g. aggreccan
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US169768 | 1998-10-09 | ||
US09/169,768 US6492508B1 (en) | 1996-06-03 | 1998-10-09 | Nucleic acids encoding extracellular matrix proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69938579D1 true DE69938579D1 (de) | 2008-06-05 |
DE69938579T2 DE69938579T2 (de) | 2009-06-04 |
Family
ID=22617093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69938579T Expired - Lifetime DE69938579T2 (de) | 1998-10-09 | 1999-10-07 | Extrazelluläre Matrixproteine mit modifizierten Aminosäuren |
Country Status (5)
Country | Link |
---|---|
US (3) | US6492508B1 (de) |
EP (2) | EP0992586B1 (de) |
CA (4) | CA2284397C (de) |
DE (1) | DE69938579T2 (de) |
ES (1) | ES2303364T3 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6927287B1 (en) * | 1996-06-03 | 2005-08-09 | United States Surgical Corporation | Nucleic acid encoding extracellular matrix protein or fragment thereof |
CA2358517C (en) | 1999-01-06 | 2012-10-09 | University Of Southern California | Method and composition for angiogenesis inhibition |
WO2001004157A2 (en) | 1999-07-13 | 2001-01-18 | University Of Southern California | NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
FR2807436B1 (fr) * | 2000-04-10 | 2002-05-24 | Meristem Therapeutics | Methode d'obtention de fibres d'un polypeptide collagenique recombinant non-hydroxyle, et fibres de polypeptide collagenique recombinant non-hydroxyle ainsi obtenues |
WO2003035692A2 (en) * | 2001-10-23 | 2003-05-01 | The Victoria University Of Manchester | Modified peptides and their uses |
US7365167B2 (en) | 2001-11-26 | 2008-04-29 | Cell Matrix, Inc. | Humanized collagen antibodies and related methods |
US7390885B2 (en) | 2001-11-26 | 2008-06-24 | Cell Matrix, Inc. | Humanized collagen antibodies and related methods |
KR20050010778A (ko) * | 2002-05-03 | 2005-01-28 | 밀레늄 바이올로직스 인코포레이티드 | 결합조직 자극 펩티드 |
WO2006130190A2 (en) * | 2005-02-07 | 2006-12-07 | Dickman Martin B | Proline suppresses apoptosis |
US10183986B2 (en) | 2005-12-15 | 2019-01-22 | Industrial Technology Research Institute | Trimeric collagen scaffold antibodies |
US20110177524A1 (en) * | 2008-07-09 | 2011-07-21 | Profibrix Bv | Recombinant Fibrinogen |
WO2010071938A1 (en) * | 2008-12-24 | 2010-07-01 | Commonwealth Scientific And Industrial Research Organisation | Novel collagen constructs |
WO2011065940A1 (en) | 2009-11-24 | 2011-06-03 | Biogen Idec Ma Inc. | Method of supplementing culture media to prevent undesirable amino acid substitutions |
EP2876165A1 (de) | 2013-11-22 | 2015-05-27 | ACIB GmbH | Verbessertes Verfahren zur Herstellung modifizierter Target-Polypeptide |
Family Cites Families (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US495527A (en) * | 1893-04-18 | Game apparatus | ||
US4066658A (en) | 1975-08-11 | 1978-01-03 | Hoffmann-La Roche Inc. | Resolution of d,l-dehydroproline |
US4294753A (en) | 1980-08-04 | 1981-10-13 | The Regents Of The University Of California | Bone morphogenetic protein process |
US4761471A (en) | 1980-08-04 | 1988-08-02 | The Regents Of The University Of California | Bone morphogenetic protein composition |
US4789732A (en) | 1980-08-04 | 1988-12-06 | Regents Of The University Of California | Bone morphogenetic protein composition |
US4455226A (en) | 1980-12-22 | 1984-06-19 | Solmat Systems, Ltd. | Method and apparatus for treating the surface of a body of liquid |
US4472840A (en) | 1981-09-21 | 1984-09-25 | Jefferies Steven R | Method of inducing osseous formation by implanting bone graft material |
US4434094A (en) | 1983-04-12 | 1984-02-28 | Collagen Corporation | Partially purified osteogenic factor and process for preparing same from demineralized bone |
US4804744A (en) | 1984-01-04 | 1989-02-14 | International Genetic Engineering, Inc. | Osteogenic factors |
US4526909A (en) | 1984-01-09 | 1985-07-02 | Regents Of The University Of California | Polymethylmethacrylate delivery system for bone morphogenetic protein |
US4563489A (en) | 1984-02-10 | 1986-01-07 | University Of California | Biodegradable organic polymer delivery system for bone morphogenetic protein |
US4608199A (en) | 1984-03-20 | 1986-08-26 | Arnold Caplan | Bone protein purification process |
US4596574A (en) | 1984-05-14 | 1986-06-24 | The Regents Of The University Of California | Biodegradable porous ceramic delivery system for bone morphogenetic protein |
EP0169016B2 (de) | 1984-07-16 | 2004-04-28 | Celtrix Pharmaceuticals, Inc. | Knorpel-induzierende Polypeptid-Faktoren aus Knochen |
US4843063A (en) | 1984-07-16 | 1989-06-27 | Collagen Corporation | Polypeptide cartilage-inducing factors found in bone |
US4627982A (en) | 1984-07-16 | 1986-12-09 | Collagen Corporation | Partially purified bone-inducing factor |
US4563350A (en) | 1984-10-24 | 1986-01-07 | Collagen Corporation | Inductive collagen based bone repair preparations |
US4681763A (en) | 1985-06-11 | 1987-07-21 | University Of Medicine And Dentistry Of New Jersey | Composition for stimulating bone growth |
JPH0662679B2 (ja) | 1985-06-21 | 1994-08-17 | 新田ゼラチン株式会社 | 組織親和性コラ−ゲンとその製法 |
US4725234A (en) | 1985-08-15 | 1988-02-16 | Ethridge Edwin C | Alveolar bone grafting process with controlled surface active ceramics |
US4798885A (en) | 1986-02-07 | 1989-01-17 | Genentech, Inc. | Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain |
US4737578A (en) | 1986-02-10 | 1988-04-12 | The Salk Institute For Biological Studies | Human inhibin |
US5108922A (en) | 1986-07-01 | 1992-04-28 | Genetics Institute, Inc. | DNA sequences encoding BMP-1 products |
ZA874681B (en) | 1986-07-01 | 1988-04-27 | Genetics Inst | Novel osteoinductive factors |
US5106748A (en) | 1986-07-01 | 1992-04-21 | Genetics Institute, Inc. | Dna sequences encoding 5 proteins |
US5187076A (en) | 1986-07-01 | 1993-02-16 | Genetics Institute, Inc. | DNA sequences encoding BMP-6 proteins |
US5013649A (en) | 1986-07-01 | 1991-05-07 | Genetics Institute, Inc. | DNA sequences encoding osteoinductive products |
DE286239T1 (de) | 1987-03-10 | 1994-02-24 | New England Biolabs Inc | Herstellung und Reinigung eines Proteins, das mit einem Bindungsprotein fusioniert ist. |
IT1214505B (it) | 1987-03-12 | 1990-01-18 | Gentili Ist Spa | Procedimento per la preparazione di collageno e prodotti cosi'ottenuto. |
CA1339083C (en) | 1987-11-13 | 1997-07-29 | Steven R. Jefferies | Bone repair material and delayed drug delivery system |
US4857476A (en) | 1988-01-26 | 1989-08-15 | Hewlett-Packard Company | Bipolar transistor process using sidewall spacer for aligning base insert |
IL89869A0 (en) | 1988-04-06 | 1989-12-15 | Collagen Corp | Bone-inducing protein |
ATE231523T1 (de) | 1988-04-08 | 2003-02-15 | Stryker Corp | Osteogene vorrichtungen |
US5250302A (en) | 1988-04-08 | 1993-10-05 | Stryker Corporation | Osteogenic devices |
US4968590A (en) | 1988-04-08 | 1990-11-06 | Stryker Corporation | Osteogenic proteins and polypeptides |
US5011691A (en) | 1988-08-15 | 1991-04-30 | Stryker Corporation | Osteogenic devices |
EP0449839A1 (de) | 1988-09-30 | 1991-10-09 | AlliedSignal Inc. | Bakterielle stämme zur heterologen genexpression |
US5106626A (en) | 1988-10-11 | 1992-04-21 | International Genetic Engineering, Inc. | Osteogenic factors |
US4891359A (en) | 1988-12-08 | 1990-01-02 | Johnson & Johnson Patient Care, Inc. | Hemostatic collagen paste composition |
AU5654990A (en) | 1989-04-28 | 1990-11-29 | Brigham And Women's Hospital | Novel materials and methods for guided tissue regeneration |
CA2017466A1 (en) | 1989-06-02 | 1990-12-02 | Michael C. Kiefer | Bone calcification factor |
CA2020729A1 (en) | 1989-07-19 | 1991-01-20 | Michael C. Kiefer | Bone morphogenetic protein |
JPH05500503A (ja) | 1989-08-21 | 1993-02-04 | セルトリックス ファーマシューティカルズ、インコーポレイテッド | 骨特異的タンパク質 |
US5358857A (en) | 1989-08-29 | 1994-10-25 | The General Hospital Corp. | Method of preparing fusion proteins |
DE69027961T2 (de) | 1989-09-06 | 1997-01-09 | Chichibu Onoda Cement Corp | Protein, DNA und ihre Verwendung |
DK0448704T3 (da) | 1989-10-17 | 1999-04-06 | Stryker Corp | Osteogene anordninger |
DE69131574T2 (de) | 1990-05-14 | 2000-05-04 | Gary R. Jernberg | Chirurgisches implantat und verfahren zum einbetten von chemotherapeutika |
US5168050A (en) | 1990-05-24 | 1992-12-01 | Genentech, Inc. | Mammalian expression of the bone morphogenetic protein-2b using bmp2a/bmp2b fusion |
ATE253589T1 (de) | 1990-09-26 | 2003-11-15 | Inst Genetics Llc | Bmp-5-derivate |
ES2087207T3 (es) | 1990-11-23 | 1996-07-16 | American Cyanamid Co | Factor del crecimiento de fibroblasto quimerico. |
US5208219A (en) | 1991-02-14 | 1993-05-04 | Celtrix Pharmaceuticals Inc. | Method for inducing bone growth |
US5118667A (en) | 1991-05-03 | 1992-06-02 | Celtrix Pharmaceuticals, Inc. | Bone growth factors and inhibitors of bone resorption for promoting bone formation |
CA2102808A1 (en) | 1991-05-10 | 1992-11-11 | Hanne Bentz | Targeted delivery of bone growth factors |
CZ282231B6 (cs) | 1991-06-05 | 1997-06-11 | The Procter And Gamble Company | Prostředek na generování nového růstu kosti v savci |
US5593859A (en) | 1991-10-23 | 1997-01-14 | Thomas Jefferson University | Synthesis of human procollagens and collagens in recombinant DNA systems |
AU663328B2 (en) | 1991-06-21 | 1995-10-05 | Genetics Institute, Llc | Pharmaceutical formulations of osteogenic proteins |
KR100255415B1 (ko) | 1991-06-25 | 2000-05-01 | 브루스 엠. 에이센 | 비엠피-9 조성물 |
US5171579A (en) | 1991-10-11 | 1992-12-15 | Genetics Institute, Inc. | Formulations of blood clot-polymer matrix for delivery of osteogenic proteins |
JP2829405B2 (ja) | 1991-10-14 | 1998-11-25 | 寳酒造株式会社 | 機能性ポリペプチド |
US5667839A (en) * | 1993-01-28 | 1997-09-16 | Collagen Corporation | Human recombinant collagen in the milk of transgenic animals |
EP0759762A4 (de) * | 1994-05-02 | 1999-09-01 | Squibb & Sons Inc | Rekombinante fibrinketten, fibrin und fibrinhomologe |
DE69528128T2 (de) * | 1994-06-10 | 2003-03-13 | United States Surgical Corp., Norwalk | Rekombinante Chimäre Proteine und Verfahren zur deren Verwendung |
WO1997004123A1 (en) * | 1995-07-19 | 1997-02-06 | Gel Tech Group Inc. | Collagen compound production in plants |
AU3056697A (en) * | 1996-04-12 | 1997-11-07 | Academy Of Finland | Synthesis of human procollagens and collagens in recombinant dna systems |
US5821089A (en) | 1996-06-03 | 1998-10-13 | Gruskin; Elliott A. | Amino acid modified polypeptides |
US6428978B1 (en) * | 1998-05-08 | 2002-08-06 | Cohesion Technologies, Inc. | Methods for the production of gelatin and full-length triple helical collagen in recombinant cells |
WO2000014201A1 (en) * | 1998-09-09 | 2000-03-16 | United States Surgical Corporation | Polypeptides containing modified, non-natural amino acids and methods of production |
-
1998
- 1998-10-09 US US09/169,768 patent/US6492508B1/en not_active Expired - Fee Related
-
1999
- 1999-10-06 CA CA002284397A patent/CA2284397C/en not_active Expired - Fee Related
- 1999-10-06 CA CA002639620A patent/CA2639620A1/en not_active Abandoned
- 1999-10-06 CA CA002639637A patent/CA2639637A1/en not_active Abandoned
- 1999-10-06 CA CA002639757A patent/CA2639757A1/en not_active Abandoned
- 1999-10-07 EP EP99119184A patent/EP0992586B1/de not_active Expired - Lifetime
- 1999-10-07 DE DE69938579T patent/DE69938579T2/de not_active Expired - Lifetime
- 1999-10-07 ES ES99119184T patent/ES2303364T3/es not_active Expired - Lifetime
- 1999-10-07 EP EP08002530A patent/EP1914311A1/de not_active Withdrawn
-
2002
- 2002-03-22 US US10/104,793 patent/US20050196830A1/en not_active Abandoned
- 2002-03-22 US US10/104,889 patent/US6958223B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2639757A1 (en) | 2000-04-09 |
EP0992586A2 (de) | 2000-04-12 |
US6958223B2 (en) | 2005-10-25 |
CA2639637A1 (en) | 2000-04-09 |
CA2284397C (en) | 2008-12-16 |
DE69938579T2 (de) | 2009-06-04 |
EP0992586A3 (de) | 2004-04-21 |
CA2284397A1 (en) | 2000-04-09 |
US20050196830A1 (en) | 2005-09-08 |
US20040086961A1 (en) | 2004-05-06 |
CA2639620A1 (en) | 2000-04-09 |
US6492508B1 (en) | 2002-12-10 |
EP0992586B1 (de) | 2008-04-23 |
ES2303364T3 (es) | 2008-08-01 |
EP1914311A1 (de) | 2008-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI953837A (fi) | Synteettisiä aktivoituvia aminohappoja | |
DE59813840D1 (de) | Protein mit phospholipaseaktivität | |
NO20001242D0 (no) | April - et nytt protein med veksteffekter | |
DE69826639D1 (de) | Chirurgische artikel hergestellt aus polyesteramiden mit von aminosäuren abstammenden gruppen und dazu alternierend mit von alpha-hydroxysäuren abstammenden gruppen | |
DK1049788T3 (da) | Proteinekspression i baculovirus-vektorekspressionssystemer | |
NO20002990L (no) | Nytt overflateprotein | |
NO20000700D0 (no) | Interleukin-18-proteiner samt fremstilling og anvendelse derav | |
ATE225776T1 (de) | Bicyclische aromatische aminosäuren | |
ATE238984T1 (de) | Sulfonylaminocarbonsäuren | |
ATE259349T1 (de) | Neue aminosäurederivate mit verbesserter multidrogenresistenz-aktivität | |
DE69938579D1 (de) | Extrazelluläre Matrixproteine mit modifizierten Aminosäuren | |
DE60328469D1 (de) | Aminosäuren mit affinität zu alpha-2-delta-protein | |
DE19882020D2 (de) | Thermo-optischer Schalter mit seitlich versetzten Element | |
ATE230926T1 (de) | Synergistische mischungen von ausgewählten aminosäuren | |
NO980566D0 (no) | Allergen-XCD32 fusjonsproteiner | |
MX219629B (es) | Metodo para separar proteinas de fusion | |
ZA98642B (en) | Immune-modulation with amino acids | |
NO20021275D0 (no) | Transgent produserte fusjonsproteiner | |
DE60040903D1 (de) | Aminosäuren enthaltende albuminpräparationen | |
DE69823225D1 (de) | Fusionsproteine, bestehend aus proteinaseinhibitoren | |
NO980375D0 (no) | Humant MP52 Arg protein | |
FI971085A0 (fi) | Uusia PKA:ta sitovia proteiineja ja näiden käyttömuotoja | |
NO20005547D0 (no) | Myelinbasiske proteinpeptider og anvendelser derav | |
NO20021244D0 (no) | Subenhet-optimaliserte fusjonsproteiner | |
ATA114093A (de) | Markierte alpha aminosäuren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |